This Strategy serves as a foundational component of the President’s vision to create a world free from catastrophic biological incidents, laying out a set of objectives to effectively counter the spectrum of biological threats. It defines biodefense as actions to counter biological threats, reduce biological risks, and prepare for, respond to, and recover from biological incidents, whether naturally occurring, accidental, or deliberate in origin and whether impacting human, animal, plant, or environmental health. Therefore the Strategy describes the goals and objectives that will guide the United States in assessing biological risks and developing risk-mitigation measures. The Strategy implements a coordinated One Health approach as a best practice for understanding, communicating, and mitigating biological threats. The Strategy also concerns the implementation plan with an early warning system, the strengthening of country capacities to prevent bioincidents, the capacity to conduct biological research, accelerating biosecurity innovation, investments in domestic public health capacities, promotion of vaccination against any human or animal viral threat and increasing vaccine production and distribution, limitation of environmental impact resulting from biological incidents. The Strategy has five goals with associated objectives for strengthening the biodefense enterprise, establishing a layered risk management approach to countering biological threats and incidents: 1) enabling risk awareness and detection to inform decision-making across the biodefense enterprise, through the following objectives: ensuring decision-making is informed by intelligence, forecasting, and risk assessment; ensuring that domestic and global biothreats detection, biosurveillance, and information systems are coordinated, integrated, and capable of enabling timely bioincident prevention; 2) ensuring biodefense enterprise capabilities to prevent bioincidents, through the following objectives: promoting measures to prevent or reduce the spread of infectious diseases; strengthening global health security capacities internationally to prevent local bioincidents from becoming epidemics; preventing nation-state and non-state actors’ attempts to pursue, acquire, or use biological weapons, related materials, or their means of delivery; strengthening biosafety and biosecurity practices and oversight to prevent bioincidents and reduce biological risks; 3) ensuring biodefense enterprise preparedness to reduce the impacts of bioincidents, through the following objectives: promoting a vibrant, safe, and secure domestic and international science and technology base to support biodefence; ensuring a strong public, veterinary, and plant health infrastructure; developing prevention, response, and recovery plans and capabilities, including efforts to secure critical supply chains; updating risk communication plans and promote consistent, plain language messaging; enhancing preparedness to save lives through development, testing, evaluation, manufacturing, regulatory approval, distribution, and administration of countermeasures; limiting the spread of infectious diseases; supporting decontamination, waste management, environmental controls, and other methods of suppressing pathogens during a biological event; 4) rapidly responding to limit the impacts of bioincidents; 5) facilitating the recovery to restore the community, the economy, and the environment after a bioincident.
Estados Unidos de América · 2022-10-01